News
Important Only
A Minute With: 'Hijack' star Idris Elba on hostage thriller return
By Marie-Louise GumuchianLONDON, Jan 9 (Reuters) - Actor Idris Elba faces another crisis in season two of thriller series "Hijack", when passengers on a Berlin underground train are taken hostage during the morning rush hour.Two years after his character, Sam Nelson, survived a plane hijacki...Reuters
Fri, Jan 9
Pds Biotech Announces FDA Alignment On Use Of Progression Free Survival (Pfs) As Primary Endpoint
Jan 9 (Reuters) - PDS Biotechnology Corp PDSB.O:PDS BIOTECH ANNOUNCES FDA ALIGNMENT ON USE OF PROGRESSION FREE SURVIVAL (PFS) AS PRIMARY ENDPOINTPDS BIOTECHNOLOGY CORP - AMENDMENT CHANGES PFS TO PRIMARY ENDPOINT FOR ACCELERATED APPROVALPDS BIOTECHNOLOGY CORP - MEDIAN OVERALL SURVIVAL REMAINS PRIMARY...Reuters
Fri, Jan 9
Meloni does not believe US will make military move on Greenland, urges strong NATO Arctic presence
Italy PM urges stronger NATO presence in ArcticMeloni says a US move on Greenland would hurt NATOSays disagrees with Trump, defends international lawBy Giselda Vagnoni and Crispian Balmer ROME, Jan 9 (Reuters) - Italian Prime Minister Giorgia Meloni said she did not believe the United States woul...Reuters
Fri, Jan 9
Rocket Doctor Ai Announces Listed Issuer Financing Exemption (Life) Non-Brokered Private Placement
Jan 9 (Reuters) - Rocket Doctor AI Inc AIDR.CD:ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENTROCKET DOCTOR AI INC - ANNOUNCES PRIVATE PLACEMENT OF 4,285,715 UNITSROCKET DOCTOR AI INC - PRICE PER UNIT SET AT $0.70 FOR $3 MILLION PROCEEDSReuters
Fri, Jan 9
Altus Group Ltd Announces Preliminary Results Of Substantial Issuer Bid
Jan 9 (Reuters) - Altus Group Ltd AIF.TO:ALTUS GROUP LTD - ANNOUNCES PRELIMINARY RESULTS OF SUBSTANTIAL ISSUER BIDALTUS GROUP LTD - TO PURCHASE 2,849,643 SHARES AT C$57.00 EACHALTUS GROUP LTD - AGGREGATE PURCHASE PRICE ABOUT C$162.43 MILLIONReuters
Fri, Jan 9
Madrigal Expands Its Mash Pipeline With Exclusive Global License Agreement For Ervogastat
Jan 9 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:MADRIGAL EXPANDS ITS MASH PIPELINE WITH EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR ERVOGASTAT, A PHASE 2 ORAL DGAT-2 INHIBITORMADRIGAL PHARMACEUTICALS INC - PFIZER RECEIVES $50 MILLION UPFRONT PAYMENT FROM MADRIGALMADRIGAL PHARMACEUTICALS INC - PLANS...Reuters
Fri, Jan 9
Orca Bio Announces $250 Million In Aggregate Financing
Jan 9 (Reuters) - ORCA BIO ANNOUNCES $250M IN AGGREGATE FINANCING IN PREPARATION FOR POTENTIAL COMMERCIALIZATIONORCA BIO - COMPLETION OF A SERIES F FINANCING ROUND IN DECEMBER 2025 LED BY LIGHTSPEED VENTURE PARTNERSFurther company coverage: [ ]Reuters
Fri, Jan 9
US quits global organisation dedicated to preventing violent extremism
GCERF highlights increased extremist violence risk in Sahel and AfghanistanContinuing prevention work despite Trump administration's withdrawalGlobal Terrorism Index shows increase in countries experiencing attacksBy Olivia Le Poidevin GENEVA, Jan 9 (Reuters) - A global organisation dedicated...Reuters
Fri, Jan 9
Airnexis Therapeutics Raises $200 Million Series A
Jan 9 (Reuters) - AIRNEXIS THERAPEUTICS LAUNCHES WITH $200M SERIES A TO ADVANCE PHASE 2 DUAL PDE3/4 INHIBITOR AN01 FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)AIRNEXIS THERAPEUTICS: OVER-SUBSCRIBED SERIES A WAS LED BY FRAZIER LIFE SCIENCESFurther company coverage: [ ]Reuters
Fri, Jan 9
Revvity Collaborates With Lilly To Expand Access To Ai Drug Discovery Models
Jan 9 (Reuters) - Revvity Inc RVTY.N:REVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELSREVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELSREVVITY INC: COLLABORATION FUNDS PARTICIPATING BIOTECHS TO ACCESS LILLY PREDICTIVE MODELS THROUGH REVVITY SIGNA...Reuters
Fri, Jan 9
